Stock Screener App

무료 -

설치하다

1.97

3.14% 0.06

Caribou Biosciences Inc (CRBU)

개요 뉴스 가격 이력 옵션 체인 Financials CRBU 왜 하락? 토론 예측

Caribou Biosciences Inc 주식(CRBU)의 최신 뉴스

Signal Recap: Is Caribou Biosciences Inc stock good for income investors2026 Macro Moves & Precise Swing Trade Alerts - baoquankhu1.vn

Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value - Seeking Alpha

Caribou Biosciences Teases vispa-cel Phase 3 LBCL Plan, Eyes Financing at Leerink Conference - MarketBeat

CRBU Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Ardent Health Partners, Inc. (ARDT) and Caribou Biosciences (CRBU) - The Globe and Mail

Drug Pricing Reforms Threaten Caribou Biosciences’ Future Margins and Market Access - The Globe and Mail

Caribou Biosciences: Advancing Allogeneic Cell Therapy Pipeline and Pivotal Trial Plans Support High-Risk Buy Rating - TipRanks

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Cencora (COR) and Caribou Biosciences (CRBU) - The Globe and Mail

Truist reiterates Buy on Caribou Biosciences stock, $7 target - Investing.com Australia

Truist reiterates Buy on Caribou Biosciences stock, $7 target By Investing.com - Investing.com UK

Caribou Biosciences, Inc. (CRBU) reports Q4 loss, tops revenue estimates - MSN

Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - Investing News Network

Caribou Biosciences earnings beat by $0.04, revenue topped estimates - Investing.com Canada

Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Caribou Biosciences (NASDAQ:CRBU) Posts Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat

Caribou Biosciences announces Q4 and FY2025 financial results - Traders Union

Caribou Biosciences Q4 licensing revenue rises, net loss narrows - TradingView

Insights into Caribou Biosciences Q4 Earnings - Benzinga

Caribou Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

CRBU: Strong clinical progress and improved financials position the pipeline for pivotal trials - TradingView

Caribou Biosciences (Nasdaq: CRBU) details 2025 loss and CAR-T trial plans - Stock Titan

BRIEF-Caribou Biosciences Q4 Licensing And Collaboration Revenue USD 3.941 Million - TradingView

Caribou Biosciences Stock Soars Pre-market On Positive Early Trial Data For Cancer Treatments - Stocktwits

CRBU Earnings History & Surprises | EPS & Revenue Results | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill

CRBU Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Caribou Biosciences (CRBU) to Release Earnings on Monday - MarketBeat

Insider Sell: Timothy Kelly Sells Shares of Caribou Biosciences Inc (CRBU) - GuruFocus

Caribou Biosciences Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView

Caribou Biosciences (CRBU) CTO sells 6,228 shares in open-market trade - Stock Titan

7 Top Gene-Editing Stocks to Buy - US News Money

Caribou Biosciences (NASDAQ: CRBU) notice to sell 6,938 vested shares - Stock Titan

Caribou Biosciences (NASDAQ: CRBU) files Rule 144 to sell 6,938 shares - Stock Titan

Timothy Kelly sells 3,147 CRBU shares; proposed sale of 6,228 restricted shares (CRBU) - Stock Titan

Decliners Report: Is Roivant Sciences Ltd stock undervalued right nowJuly 2025 Update & Daily Growth Stock Tips - baoquankhu1.vn

Caribou Biosciences (NASDAQ:CRBU) Insider Ruhi Ahmad Khan Sells 6,938 Shares - MarketBeat

Caribou Biosciences CLO sold $13,598 in CRBU stock - Investing.com Australia

Caribou Biosciences CLO sold $13,598 in CRBU stock By Investing.com - Investing.com Canada

Caribou Biosciences CTO Kelly sells $6.1k in shares By Investing.com - Investing.com Canada

Khan, Caribou Biosciences CBO, sells $13598 in stock - Investing.com Australia

Khan, Caribou Biosciences CBO, sells $13598 in stock By Investing.com - Investing.com Canada

Caribou Biosciences (CRBU) CBO awarded stock options, sells shares for tax - Stock Titan

[Form 4] Caribou Biosciences, Inc. Insider Trading Activity - Stock Titan

Growth Value: Is Caribou Biosciences Inc benefiting from interest rate changesMarket Risk Report & Intraday High Probability Alerts - baoquankhu1.vn

Earnings Risk: Is Magyar Bancorp Inc stock a falling knife or bargain buyJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - baoquankhu1.vn

Caribou Biosciences Details Pivotal-Ready Vispa-cel Plan, Flags Need for More Capital at Citi Summit - MarketBeat

Should you avoid Caribou Biosciences Inc. stock right now2025 Earnings Impact & Weekly Watchlist for Consistent Profits - mfd.ru

Volume Report: Is NCIQ stock forming a cup and handleSwing Trade & Weekly High Potential Alerts - baoquankhu1.vn

Short Squeeze: How does Caribou Biosciences Inc compare to its peersInflation Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn

Caribou Biosciences (CRBU) Receives a Buy from Citi - The Globe and Mail

Caribou Biosciences (CRBU)’s CB-011 may reach $734 million in peak 2040 sales, according to Clear Street - MSN

Director at Caribou Biosciences (CRBU) awarded option for 45,000 shares - Stock Titan

Caribou Biosciences (CRBU) CEO receives large new equity grants - Stock Titan

Is Caribou Biosciences Inc. stock a top performer YTDWeekly Trade Report & Low Drawdown Momentum Trade Ideas - mfd.ru

Caribou Biosciences (CRBU)’s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street - Yahoo Finance

Caribou Biosciences (CRBU)'s CB-011 May Reach $734 Million in Peak 2040 Sales, According to Clear Street - Finviz

Is Caribou Biosciences Inc. stock risky to hold nowJuly 2025 Outlook & AI Forecasted Stock Moves - mfd.ru

RVMD

$99.29

1.20%

ROIV

$27.80

0.00%

MRNA

$52.37

0.06%

BNTX

$89.31

0.77%

INSM

$144.00

0.91%

ONC

$282.72

0.15%

야후에서 열기 | 구글에서 열기 | 핀비즈에서 열기 | MarketWatch에서 열기 | EDGAR에서 열기 | 로이터에서 공개